Melody Harris - 21 Feb 2025 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
25 Feb 2025, 16:40:26 UTC
Prior SEC filing
16 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Ali Olivo, Attorney-in-Fact

Key filing fact

Melody Harris filed Form 4 for NEOGENOMICS INC (NEO) on 25 Feb 2025.

Key facts

  • This page summarizes Melody Harris's Form 4 filing for NEOGENOMICS INC (NEO).
  • 5 reported transactions and 13 derivative rows are listed below.
  • Accepted by SEC: 25 Feb 2025, 16:40.

Change

  • Previous filing in this sequence was filed on 16 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NEO transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+8,443
Change %
+8.2%
Price
$0.000000
Shares after
111,811
Date
23 Feb 2025
Ownership
Direct
Footnotes
F1, F2
NEO transaction

Common Stock

Tax liability

Transaction value
$0
Shares
-2,056
Change %
-1.8%
Price
$0.000000
Shares after
109,755
Date
23 Feb 2025
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NEO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+143,266
Change %
Price
$0.000000
Shares after
143,266
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
143,266
Exercise price
$13.05
Footnotes
F4, F5
NEO transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+84,317
Change %
Price
$0.000000
Shares after
84,317
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
84,317
Exercise price
$0.000000
Footnotes
F6, F7
NEO transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-8,443
Change %
-33%
Price
$0.000000
Shares after
16,886
Date
23 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,443
Exercise price
$0.000000
Footnotes
F7, F8
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
201,613
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
201,613
Exercise price
$9.24
Footnotes
F9
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
39,683
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
39,683
Exercise price
$19.65
Footnotes
F10
NEO holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
14,136
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
14,136
Exercise price
$0.000000
Footnotes
F7, F11
NEO holding Derivative

Performance Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
21,204
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
21,204
Exercise price
$0.000000
Footnotes
F7, F12
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
42,344
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
42,344
Exercise price
$16.45
Footnotes
F13
NEO holding Derivative

Performance Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
25,330
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,330
Exercise price
$0.000000
Footnotes
F7, F14
NEO holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
19,984
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
19,984
Exercise price
$13.96
Footnotes
F15
NEO holding Derivative

Performance Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,939
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,939
Exercise price
$0.000000
Footnotes
F7, F16
NEO holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,939
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,939
Exercise price
$0.000000
Footnotes
F7, F17
NEO holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
59,382
Date
21 Feb 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
59,382
Exercise price
$0.000000
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 17 footnotes

Footnote F1

Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.

Footnote F2

This balance includes 548 shares that were acquired pursuant to NeoGenomics' Employee Stock Purchase Plan. The shares were acquired in transactions exempt from Section 16b-3.

Footnote F3

Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.

Footnote F4

This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 20, 2025 and multiplied by 110%.

Footnote F5

On February 21, 2025, Ms. Harris was granted 143,266 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Footnote F6

On February 21, 2025, Ms. Harris was granted 84,317 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Footnote F7

Once vested, the shares of common stock are not subject to expiration.

Footnote F8

On February 23, 2024, Ms. Harris was granted 25,329 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Footnote F9

On January 1, 2023, Ms. Harris was granted 201,613 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Footnote F10

On May 11, 2023, Ms. Harris was granted 39,683 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Footnote F11

On May 11, 2023, Ms. Harris was granted 21,204 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

Footnote F12

On May 11, 2023, Ms. Harris was granted 21,204 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is31,806. The number of performance stock units that may vest is based on the achievement of certain share growth goals based on the weighted average price of the Company's common stockover the 20-day trailing trading period at theapplicable measurement dates, subject to continued service with the Company.

Footnote F13

On February 23, 2024, Ms. Harris was granted 42,344 stock options. These options vest ratably over the first three anniversary dates of the grant date

Footnote F14

On February 23, 2024, Ms. Harris was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant tothe performance criteria is37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period atthe applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of thecumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

Footnote F15

On May 2, 2024, Ms. Harris was granted 19,984 stock options. These options vest ratably over the first three anniversary dates of the grant date.

Footnote F16

On May 2, 2024, Ms. Harris was granted 11,939 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to theperformance criteria is17,909. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company'scommon stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based onthe achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.

Footnote F17

On May 2, 2024, Ms. Harris was granted 11,939 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .